2Poort SR, Rosendaal FR, Reitsma PH, et al. A common genetic variation in the 3 '-untranslated region of the prothrombin gene is assiciated with e- lected plasma prothrombin levels and an increase in venous thrombosis [ J]. Blood, 1996 ;88:3689.
3Jodi B, Segal MD. Predictive value of factor V leiden and prothrombin G20210A in aduhs with venous thromboembolism and in family members of those with a mutation [ J ]. JAMA, 2009 ; 301 ( 23 ) : 2472-85.
4Ahmad-Nejad P, Dempfle CE, Borggrefe M, et al. The G534E-polymor- phism of the gene encoding the factor VII-activating protease is a risk fac- tor for venous thrombosis and recun'ent events [ J]. Thrombosis Res, 2012 ; 130:4414.
5Ruiz-Argtielles G, Garc6s-Eisele J, Rwyws-Ntiez V, et al. Primary throm- bphilia in Mexico. 11 . factor V G1691A ( Leiden ), prothrombin G20210A,and methylenetetrahydrofolate reductase C677T polymorphism in thrombophilic Mexican Mestizos[ J]. Am J Hematol,2001 ;66:28-31.
6Kovac M, Mitic G, Mikovic Z, et al. Type and location of venous thrombo- embolism in carriers of factor V leiden or prothrombin G20210A mutation versus patients with no mutation [ J]. Clin Appl Thromb Hemost,2010 ; 16 ( 1 ) :66-70.
7Zalavras CG,Giotopoulou S, Dokou E, et al. Prevalence of the G20210A prothrombin gene mutation in Northwestern Greece and association with venous thromboembolism [ J]. Intern Angio1,2003 ;22 ( 1 ) :55-7.
8Barcellona D,Fenu L,Cauli C,et al. Allele 4G of gene PAI-I associated with prothrombin mutation G20210A increases the risk for venous thrombosis [ J]. Thromb Haemost ,2003 ;90 (6) : 1061-4.
9Okumus G, Kiyan E, Arseven O, et al. Hereditary thrombophilic risk factors and venous thromboembotism in istanbul,turkey:the role in dif- ferent clinical manifestations of venous thromboembolism[J]. Clin Appl Thromb Hemost,2008 ; 14 ( 2 ) : 168-73.
10Almawi WY, Tamim H, Kreidy R, et al. A case control study on the con- tribution of factor V-leiden,prothrombin G20210A,and MTHFR C677T mutations to the genetic susceptibility of deep venous thrombosis [ J]. J Thromb Thrombo1,2005 ; 19 ( 3 ) : 189-96.
2Sambrook JM 金冬雁等（译）.分子克隆实验指南（第2版）[M].北京:科学出版社,1993.464.
3De Stefano V,Martinelli I,Leone G,et al.The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor Ⅴ Leiden and the G20210A prothrombin mutation.N Eng J Med,1999,341(11):801.
4Gerhardt A,Scharf RE,Beckmann MW,et al.Prothrombin and factor Ⅴ mutations in women with a history of thrombosis during pregnancy and the puerperium.N Eng J Med,2000,342(6):374.
5Rosendaal FR,Doggen CJM,Zivelin A,et al.Geographic distribution of the 20210 G to a prothrombin variant.Thromb Haemost,1998,79 (4):706.
6Mansourati J,Da Costa A,Munier S,et al.Prevalence of factor Ⅴ Leiden in patients with myocardial infarction and normal coronary angiography.Thromb Haemost,2000,83(6):822.
7Linfert DR,Rezuke WN,Tsongalis GJ.Rapid multiplex analysis for the Factor V Leiden and prothrombin G20210Amutations associated with hereditary thrombophilia.Conn Med,1998,62(9):519.
8Dahlback B,Hildebrand B.Inherited resistance to activated protein C is corrected by anticoagulant cofactor activity found to be a property of factor Ⅴ.Proc.Natl.Acad Sci USA,1994,91(4):1396.
9Gregg JP,Yamane A J,Grody WW.Prevalence of the factor Ⅴ-Leiden mutation in four distinct American ethnic populations.Am J Med Genet,1997,73(3):334.
10Gurgey A,Kudayarov DK,Tuncer M,et al.The factor Ⅴ Leiden and prothrombin G20210A mutations in Kirghiz population.Thromb Haemost,2000,84 (2):356.
